Better Obesity Drug Race: Novo Nordisk vs Lilly 2026
In the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
Learn various ways to invest smartly this year, ensuring your financial growth and stability in 2023.
22,737 articlesIn the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
A 10% move in Vericel stock drew attention after a COO sold shares worth $402,000. This article breaks down what the ...
SpaceX grabs headlines, yet smart investors look for real performance. Meet two growth stocks I prefer over the hype:...
Former House Speaker Nancy Pelosi partners with UC Berkeley to launch a nonpartisan democracy institute funded with $...
A high-profile onstage moment offers more than memories—it highlights money planning for families in the spotlight. H...
Rivian CEO RJ Scaringe has signaled that rivian scaringe wants company to be judged by software and ecosystem, not ju...
A sharp global copper crunch boosts Freeport-McMoRan as the leading domestic copper king. Investors eye FCX for cash ...
A new 530A account aims to boost child wealth, but uptake is tepid as July 4 launches draws near. Experts warn billio...
Ripple unveils a day-one Open USD partnership as XRP hovers near $1, with RLUSD clearing regulatory hurdles and insti...
Investors are weighing big potential against real-world risk. This article breaks down VK2735, market dynamics, and w...
President Trump disclosed a $2.2 billion 2025 income, including roughly $1 billion from crypto. Washington’s ethics e...
The AI boom relies on more than chips. It hinges on the invisible backbone—equipment that enables chipmakers to scale...